Neisseria gonorrhoeae DNA (GC DNA)

Neisseria gonorrhoeae DNA constitutes the complete genetic material of the Gram-negative bacterium responsible for gonorrhea, a major global sexually transmitted infection. This genomic DNA serves as the essential template for all cellular processes, including the replication and transcription of virulence factors such as type IV pili and opacity (Opa) proteins that facilitate host cell attachment and invasion (NCBI, 2023). While many antibiotics target the enzymes associated with DNA processing, the DNA molecule itself is a critical component of the ternary complex targeted by fluoroquinolones, which induce lethal double-strand breaks by trapping topoisomerase enzymes on the DNA strand (StatPearls, 2023). Beyond its role as a therapeutic focal point, Neisseria gonorrhoeae DNA is the primary target for diagnostic Nucleic Acid Amplification Tests (NAATs), which are the gold standard for clinical detection due to their high sensitivity and specificity (CDC, 2021). The high genetic plasticity of this DNA, driven by horizontal gene transfer and natural transformation, contributes significantly to the rapid emergence of multi-drug resistant strains, posing a major challenge to global public health (WHO, 2023).

Other names

Gonococcal DNANeisseria gonorrhoeae genomic DNAN. gonorrhoeae genomeGC genomic DNA

Inhibition of DNA replication and transcription through the stabilization of DNA-topoisomerase complexes, leading to double-strand breaks and bacterial cell death, or direct sequence detection via hybridization in diagnostics.